$92.75Average Price Target
The highest estimate is 150.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Show more...
FAQ
What is GRAIL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GRAIL stocks are traded under the ticker GRAL V.
When is the next GRAIL earnings date?▼
GRAIL is going to release the next earnings report on November 18, 2026.
What were GRAIL earnings last quarter?▼
GRAL V earnings for the last quarter are -2.56 USD per share, whereas the estimation was -2.66 USD resulting in a +3.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GRAIL revenue for the last year?▼
GRAIL revenue for the last year amounts to 103.58M USD.
What is GRAIL net income for the last year?▼
GRAL V net income for the last year is -309.18M USD.
How many employees does GRAIL have?▼
As of October 01, 2026, the company has 910 employees.
In which sector is GRAIL located?▼
GRAIL operates in the Health & Wellness sector.
When did GRAIL complete a stock split?▼
GRAIL has not had any recent stock splits.
Where is GRAIL headquartered?▼
GRAIL is headquartered in MENLO PARK, United States.